Cargando…
New-generation filler based on cross-linked carboxymethylcellulose: study of 350 patients with 3-year follow-up
PURPOSE: In recent years there has been a growing interest in nonsurgical procedures for facial rejuvenation. Hyaluronic acid is currently the most widely used dermal filler for the treatment of facial wrinkles. However, new products with interesting features are being introduced into the market. Cr...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4293293/ https://www.ncbi.nlm.nih.gov/pubmed/25609932 http://dx.doi.org/10.2147/CIA.S74445 |
_version_ | 1782352583939063808 |
---|---|
author | Leonardis, Mauro Palange, Andrea |
author_facet | Leonardis, Mauro Palange, Andrea |
author_sort | Leonardis, Mauro |
collection | PubMed |
description | PURPOSE: In recent years there has been a growing interest in nonsurgical procedures for facial rejuvenation. Hyaluronic acid is currently the most widely used dermal filler for the treatment of facial wrinkles. However, new products with interesting features are being introduced into the market. Cross-linked carboxymethylcellulose is one of these and represents a new alternative for the correction of wrinkles and facial defects. PATIENTS AND METHODS: The retrospective, multicenter, open-label study on nasolabial folds reported here was carried out between January 2010 and April 2014 on 350 subjects between 22 and 67 years of age for a 36-month follow-up period in order to consistently and extensively assess the safety and performance of this treatment. RESULTS: The study revealed effective and durable correction of nasolabial wrinkles for periods of 9–12 months. Product reapplication over a 36-month period did not lead to an increase in adverse effects, which always remained rare and of little clinical significance, usually consisting of bruising and redness. CONCLUSION: Cross-linked carboxymethyl cellulose has been shown to be a safe and effective alternative to the resorbable products currently on the market. |
format | Online Article Text |
id | pubmed-4293293 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-42932932015-01-21 New-generation filler based on cross-linked carboxymethylcellulose: study of 350 patients with 3-year follow-up Leonardis, Mauro Palange, Andrea Clin Interv Aging Original Research PURPOSE: In recent years there has been a growing interest in nonsurgical procedures for facial rejuvenation. Hyaluronic acid is currently the most widely used dermal filler for the treatment of facial wrinkles. However, new products with interesting features are being introduced into the market. Cross-linked carboxymethylcellulose is one of these and represents a new alternative for the correction of wrinkles and facial defects. PATIENTS AND METHODS: The retrospective, multicenter, open-label study on nasolabial folds reported here was carried out between January 2010 and April 2014 on 350 subjects between 22 and 67 years of age for a 36-month follow-up period in order to consistently and extensively assess the safety and performance of this treatment. RESULTS: The study revealed effective and durable correction of nasolabial wrinkles for periods of 9–12 months. Product reapplication over a 36-month period did not lead to an increase in adverse effects, which always remained rare and of little clinical significance, usually consisting of bruising and redness. CONCLUSION: Cross-linked carboxymethyl cellulose has been shown to be a safe and effective alternative to the resorbable products currently on the market. Dove Medical Press 2015-01-06 /pmc/articles/PMC4293293/ /pubmed/25609932 http://dx.doi.org/10.2147/CIA.S74445 Text en © 2015 Leonardis and Palange. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. |
spellingShingle | Original Research Leonardis, Mauro Palange, Andrea New-generation filler based on cross-linked carboxymethylcellulose: study of 350 patients with 3-year follow-up |
title | New-generation filler based on cross-linked carboxymethylcellulose: study of 350 patients with 3-year follow-up |
title_full | New-generation filler based on cross-linked carboxymethylcellulose: study of 350 patients with 3-year follow-up |
title_fullStr | New-generation filler based on cross-linked carboxymethylcellulose: study of 350 patients with 3-year follow-up |
title_full_unstemmed | New-generation filler based on cross-linked carboxymethylcellulose: study of 350 patients with 3-year follow-up |
title_short | New-generation filler based on cross-linked carboxymethylcellulose: study of 350 patients with 3-year follow-up |
title_sort | new-generation filler based on cross-linked carboxymethylcellulose: study of 350 patients with 3-year follow-up |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4293293/ https://www.ncbi.nlm.nih.gov/pubmed/25609932 http://dx.doi.org/10.2147/CIA.S74445 |
work_keys_str_mv | AT leonardismauro newgenerationfillerbasedoncrosslinkedcarboxymethylcellulosestudyof350patientswith3yearfollowup AT palangeandrea newgenerationfillerbasedoncrosslinkedcarboxymethylcellulosestudyof350patientswith3yearfollowup |